| Symbol | ADIA |
|---|---|
| Name | ADIA NUTRITION, INC. |
| Sector | UNDEFINED |
| Region | North America |
| Industry | - |
| Address | 32789 United States FL 1561 W. Fairbanks Avenue Suite 205 |
| Telephone | +1 321-788-0850 |
| Fax | — |
| — | |
| Website | https://adianutrition.com/ |
| Incorporation | US |
| Incorporated On | 1975 |
| Employees | — |
| Fiscal Year | 12/31 |
| Public Since | — |
| Exchanges | OTC;NASDAQ |
| Auditor | Astra Audit & Advisory, LLC;H-Squared Ventures, LLC; |
| Audit Status | AUDITED |
| Reporting Status | U.S. Reporting: SEC Reporting |
| CIK | 0001160420 |
| Description | Adia Nutrition Inc. (OTC Pink: ADIA), based in Winter Park, Florida, is a publicly traded company transforming healthcare and supplementation. Its medical and supplement divisions aim to boost health and vitality through innovation and expansion. Adia Med leads with a nationwide rollout of satellite locations offering Umbilical Cord Stem Cell (UCB-SC) and exosome treatments, like AdiaVita from Adia Labs LLC, with 100 million stem cells and 3 trillion exosomes per unit. These therapies address chronic inflammation, autoimmune disorders, and orthopedic issues. Partnerships with top medical entities help expand access to regenerative medicine. Full clinics with apheresis machines will also offer Autologous Hematopoietic Stem Cell Transplantation (aHSCT) for conditions like Multiple Sclerosis and Therapeutic Plasma Exchange (TPE) for diseases like Alzheimers. The supplement division offers premium organic products, boosted by a 2024 partnership with Cement Factory LLC., including Biolete coffee with collagen and mushrooms. Adias revenue comes from service fees, product sales, and equity stakes, while pushing for standardized stem cell protocols with FDA-approved labs. Through this dual strategy, Adia is redefining healthcare and promoting wellness nationwide. Additional info from OTC: |
No news found.